Emily Y Chu (Emily Chu, E Y Chu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Systemic Lupus Erythematosus

Monoclonal Antibody

Helicobacter Pylori Infection

Top Venues

Journal of cutaneous pathology

Clinical and experimental dermatology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel J Starrett, Brittany C Baikie, Benjamin K Stoff, Hans E Grossniklaus, Inga Van Buren, Elizabeth G Berry, Roberto A Novoa, Kerri E Rieger, Kavita Y Sarin, Charles F Lynch, Michael C Royer, Mary L Piaskowski, Isaac Brownell, Emily Y Chu, Rama Godse, Suephy C Chen, Kelly J Yu, Alisa M Goldstein, Eric A Engels, Michael R Sargen
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Riyad N H Seervai, Sarah K Friske, Emily Y Chu, Rhea Phillips, Kelly C Nelson, Auris Huen, Woo Cheal Cho, Leomar Y Ballester, Carlos A Torres-Cabala, Victor G Prieto, Jonathan L Curry
The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy. Journal of cutaneous pathology (2022)
Margaret Wat, Nicholas K Mollanazar, Christoph T Ellebrecht, Amy Forrestel, Rosalie Elenitsas, Emily Y Chu
Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade. Journal of cutaneous pathology 49 (11) (2022)
Riyad N H Seervai, Woo Cheal Cho, Emily Y Chu, Mario L Marques-Piubelli, Debora A Ledesma, Kristen Richards, Meghan M Heberton, Kelly C Nelson, Priyardhisini Nagarajan, Carlos A Torres-Cabala, Victor G Prieto, Jonathan L Curry
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. Journal of cutaneous pathology 49 (1) (2021)
Susan Pei, Andrew S Fischer, Albert C Yan, Melinda Jen, Carrie L Kovarik, Emily Y Chu, Adam I Rubin
Lymphedematous verrucous changes of the genital skin: an extraintestinal manifestation of Crohn disease. Journal of cutaneous pathology 48 (4) (2021)
R Godse, S Mcgettigan, L M Schuchter, C T Ellebrecht, Emily Y Chu
Vogt-Koyanagi-Harada-like syndrome in the setting of combined anti-PD1/anti-CTLA4 therapy. Clinical and experimental dermatology 46 (6) (2021)
Anna E Kersh, Lynn M Schuchter, Rosalie Elenitsas, Emily Y Chu
Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy. Immunotherapy 12 (13) (2020)
Sophia A Ma, Conor P O'Day, Tzvete Dentchev, Junko Takeshita, Todd W Ridky, John T Seykora, Emily Y Chu
Expression of p15 in a spectrum of spitzoid melanocytic neoplasms. Journal of cutaneous pathology 46 (5) (2019)
Catherine Blebea, Dong Li, Leslie Castelo-Soccio, Emily Y Chu
Generalized congenital epithelioid blue nevi (pigmented epithelioid melanocytomas) in an infant: Report of case and review of the literature. Journal of cutaneous pathology 46 (12) (2019)
William C Fix, Sook-Jung Yun, Caroline M Groft MacFarlane, Anokhi Jambusaria, Rosalie Elenitsas, Emily Y Chu, Jeremy R Etzkorn, Joseph F Sobanko, Thuzar M Shin, Christopher J Miller
MART-1-labeled melanocyte density and distribution in actinic keratosis and squamous cell cancer in situ: Pagetoid melanocytes are a potential source of misdiagnosis as melanoma in situ. Journal of cutaneous pathology 45 (10) (2018)
Vishwas Parekh, Joseph Sobanko, Christopher J Miller, Giorgos Karakousis, Wei Xu, Richard Letrero, Rosalie Elenitsas, Xiaowei Xu, David E Elder, Ravi Amaravadi, Lynn M Schuchter, Katherine L Nathanson, Melissa A Wilson, Emily Y Chu
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. Journal of cutaneous pathology 46 (3) (2018)
Robert J Smith, Tara C Mitchell, Emily Y Chu
Pembrolizumab-induced sarcoidal infusion site reaction. Journal of cutaneous pathology (2018)
Kimberly Shao, Suzanne McGettigan, Rosalie Elenitsas, Emily Y Chu
Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy. Journal of cutaneous pathology 45 (1) (2017)
Julia Dai, Christian A Kunder, Emily Y Chu, Edward F Chan, Christine L Egan, Roberto A Novoa
Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy. Journal of cutaneous pathology 44 (12) (2017)